Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteoporosis 2Lymphoma 2Leukemia 2Breast Neoplasms 2Vitamin D Deficiency 1Polyps 1Pain 1Ovarian Neoplasms 1Obesity 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Bone Diseases, Metabolic 1Arthralgia 1Aflatoxin Poisoning 1Adenomatous Polyps 1Adenoma 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × Calcium Carbonate × Clear all
NCT00416715 2017-07-11

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer

University of Washington

Phase 2 Completed
100 enrolled 6 charts
Breast

Breast Neoplasms, Pain, Arthralgia

NCT00073073 2016-05-17

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Georgetown University

Phase 2 Completed
46 enrolled 8 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡